At a glance
- Originator Eli Lilly and Company
- Class Antibacterials; Beta-lactams; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 20 Apr 1995 No-Development-Reported for Bacterial infections in USA (Unknown route)